Abstract
Prader-Willi syndrome (PWS) is one of the most commonly recognized causes of early-onset childhood obesity. Individuals with PWS have significant hyperphagia and decreased recognition of satiety. The exact etiology of the hyperphagia remains unknown and, therefore, untreatable. We conducted a pilot, open-label study of response to metformin in 21 children with PWS and six with early morbid obesity (EMO). Participants had significant insulin resistance and glucose intolerance on oral glucose tolerance testing (OGTT) and were started on metformin for these biochemical findings. We administered the Hyperphagia Questionnaire to parents of patients before and after starting metformin treatment. Both the PWS and EMO groups showed significant improvements in food-related distress, anxiety, and ability to be redirected away from food on the Hyperphagia Questionnaire. In the PWS group, improvements were predominantly seen in females. Within the PWS group, responders to metformin had higher 2-h glucose levels on OGTT (7.48 mmol/L vs. 4.235 mmol/L; p=0.003) and higher fasting insulin levels (116 pmol/L vs. 53.5 pmol/L; p=0.04). Additionally, parents of 5/13 individuals with PWS and 5/6 with EMO reported that their child was able to feel full while on metformin (for many this was the first time they had ever described a feeling of fullness). Metformin may improve sense of satiety and decrease anxiety about food in some individuals with PWS and EMO. Positive response to metformin may depend on the degree of hyperinsulinism and glucose intolerance. Nonetheless, the results of this pilot study bear further investigation.
References
1. Cassidy SB, Driscoll DJ. Prader-Willi syndrome. Eur J Hum Genet 2009;17:3–13.10.1038/ejhg.2008.165Search in Google Scholar
2. Butler MG, Fischer W, Kibiryeva N, Bittel DC. Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. Am J Med Genet A 2008;146:854–60.10.1002/ajmg.a.32249Search in Google Scholar
3. Schrander-Stumpel CT, Curfs LM, Sastrowijoto P, Cassidy SB, Schrander JJ, et al. Prader-Willi syndrome: causes of death in an international series of 27 cases. Am J Med Genet A 2004;124A:333–8.10.1002/ajmg.a.20371Search in Google Scholar
4. Davies W, Lynn PM, Relkovic D, Wilkinson LS. Imprinted genes and neuroendocrine function. Front Neuroendocrinol 2008;29:413–27.10.1016/j.yfrne.2007.12.001Search in Google Scholar
5. Goldstone AP. The hypothalamus, hormones, and hunger: alterations in human obesity and illness. Prog Brain Res 2006;153:57–73.10.1016/S0079-6123(06)53003-1Search in Google Scholar
6. Holsen LM, Zarcone JR, Brooks WM, Butler MG, Thompson TI, et al. Neural mechanisms underlying hyperphagia in Prader-Willi syndrome. Obesity (Silver Spring) 2006;14:1028–37.10.1038/oby.2006.118Search in Google Scholar PubMed PubMed Central
7. Miller JL, James GA, Goldstone AP, Couch JA, He G, et al. Enhanced activation of reward mediating prefrontal regions in response to food stimuli in Prader-Willi syndrome. J Neurol Neurosurg Psychiatry 2007;78:615–9.10.1136/jnnp.2006.099044Search in Google Scholar PubMed PubMed Central
8. Holsen LM, Zarcone JR, Chambers R, Butler MG, Bittel DC, et al. Genetic subtype differences in neural circuitry of food motivation in Prader-Willi syndrome. Int J Obes (Lond) 2009;33:273–83.10.1038/ijo.2008.255Search in Google Scholar PubMed PubMed Central
9. Holsen LM, Savage CR, Martin LE, Bruce AS, Lepping RJ, et al. Importance of reward and prefrontal circuitry in hunger and satiety: Prader-Willi syndrome vs simple obesity. Int J Obes (Lond) 2012;36:638–47.10.1038/ijo.2011.204Search in Google Scholar PubMed PubMed Central
10. Bizzarri C, Rigamonti AE, Luce A, Cappa M, Cella SG, et al. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children. Eur J Endocrinol 2010;162:499–505.10.1530/EJE-09-1033Search in Google Scholar PubMed
11. Haqq AM, Grambow SC, Muehlbauer M, Newgard CB, Svetkey LP, et al. Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clin Endocrinol (Oxf) 2008;69:911–20.10.1111/j.1365-2265.2008.03385.xSearch in Google Scholar PubMed PubMed Central
12. Kennedy L, Bittel DC, Kibiryeva N, Kalra SP, Torto R, et al. Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects. Int J Obes (Lond) 2006;30:382–7.10.1038/sj.ijo.0803115Search in Google Scholar PubMed PubMed Central
13. Proto C, Romualdi D, Cento RM, Romano C, Campagna G, et al. Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader-Willi and the Down syndromes. Metabolism 2007;56:1076–80.10.1016/j.metabol.2007.03.016Search in Google Scholar PubMed
14. Ring LE, Zeltser LM. Disruption of hypothalamic leptin signaling in mice leads to early-onset obesity, but physiological adaptations in mature animals stabilize adiposity levels. J Clin Invest 2010;120:2931–41.10.1172/JCI41985Search in Google Scholar PubMed PubMed Central
15. Roth CL, Bongiovanni KD, Gohlke B, Woelfle J. Changes in dynamic insulin and gastrointestinal hormone secretion in obese children. J Pediatr Endocrinol Metab 2010;23: 1299–309.10.1515/jpem.2010.204Search in Google Scholar PubMed
16. Thompson JA, Regnault TR. In utero origins of adult insulin resistance and vascular dysfunction. Semin Reprod Med 2011;29:211–24.10.1055/s-0031-1275522Search in Google Scholar PubMed
17. Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, et al. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 2008;28:1982–8.10.1161/ATVBAHA.108.169722Search in Google Scholar PubMed PubMed Central
18. Yau PL, Castro MG, Tagani A, Tsui WH, Convit A. Obesity and metabolic syndrome and functional and structural brain impairments in adolescence. Pediatrics 2012;130:e856–64.10.1542/peds.2012-0324Search in Google Scholar PubMed PubMed Central
19. Miller J, Kranzler J, Liu Y, Schmalfuss I, Theriaque DW, et al. Neurocognitive findings in Prader-Willi syndrome and early-onset morbid obesity. J Pediatr 2006;149:192–8.10.1016/j.jpeds.2006.04.013Search in Google Scholar PubMed
20. McNeilly AD, Williamson R, Sutherland C, Balfour DJ, Stewart CA. High fat feeding promotes simultaneous decline in insulin sensitivity and cognitive performance in a delayed matching and non-matching to position task. Behav Brain Res 2011;217:134–41.10.1016/j.bbr.2010.10.017Search in Google Scholar PubMed
21. Debette S, Beiser A, Hoffmann U, Decarli C, O’Donnell CJ, et al. Visceral fat is associated with lower brain volume in healthy middle-aged adults. Ann Neurol 2010;68:136–44.10.1002/ana.22062Search in Google Scholar PubMed PubMed Central
22. Yau PL, Javier DC, Ryan CM, Tsui WH, Ardekani BA, et al. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia 2010;53:2298–306.10.1007/s00125-010-1857-ySearch in Google Scholar PubMed PubMed Central
23. Segura B, Jurado MA, Freixenet N, Bargalló N, Junqué C, et al. White matter fractional anisotropy is related to processing speed in metabolic syndrome patients: a case-control study. BMC Neurol 2010;10:64.10.1186/1471-2377-10-64Search in Google Scholar PubMed PubMed Central
24. Karmi A, Iozzo P, Viljanen A, Hirvonen J, Fielding BA, et al. Increased brain fatty acid uptake in metabolic syndrome. Diabetes 2010;59:2171–7.10.2337/db09-0138Search in Google Scholar PubMed PubMed Central
25. Luchsinger JA. Type 2 diabetes, related conditions, in relation and dementia: an opportunity for prevention? J Alzheimers Dis 2010;20:723–36.10.3233/JAD-2010-091687Search in Google Scholar PubMed
26. Chan NN, Feher MD, Bridges NA. Metformin therapy for diabetes in Prader-Willi syndrome J R Soc Med 1998;91:598.10.1177/014107689809101116Search in Google Scholar PubMed PubMed Central
27. Hirsch HJ, Eldar-Geva T, Benarroch F, Rubinstein O, Gross-Tsur V. Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. J Clin Endocrinol Metab 2009;94:2262–8.10.1210/jc.2008-2760Search in Google Scholar PubMed
28. Schmidt F, Kapellen TM, Wiegand S, Herbst A, Wolf J, et al; DPV-Wiss Study Group; BMBF Competence Network Diabetes. Diabetes mellitus in children and adolescents with genetic syndromes. Exp Clin Endocrinol Diabetes 2012;120:579–85.10.1055/s-0032-1306330Search in Google Scholar PubMed
29. Li J, Deng J, Sheng W, Zuo Z. Metformin attenuates Alzheimer’s disease-like neuropathology in obese, leptin-resistant mice. Pharmacol Biochem Behav 2012;101:564–74.10.1016/j.pbb.2012.03.002Search in Google Scholar PubMed PubMed Central
30. Freemark M, Bursey D. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001;107:E55.10.1542/peds.107.4.e55Search in Google Scholar PubMed
31. Dykens EM, Maxwell MA, Pantino E, Kossler R, Roof E. Assessment of hyperphagia in Prader-Willi syndrome. Obesity (Silver Spring) 2007;15:1816–26.10.1038/oby.2007.216Search in Google Scholar PubMed
32. Adler-Wailes DC, Periwal V, Ali AH, Brady SM, McDuffie JR, et al. Sex-associated differences in free fatty acid flux of obese adolescents. J Clin Endocrinol Metab 2013;98: 1676–8.10.1210/jc.2012-3817Search in Google Scholar PubMed PubMed Central
33. Newal H, Myles N, Ward PB, Samaras C, Shiers D, et al. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review. Int Clin Psychopharmacol 2012;27:69–75.10.1097/YIC.0b013e32834d0a5bSearch in Google Scholar PubMed
34. Banks WA. Brain meets body: the blood-brain barrier as an endocrine interface. Endocrinology 2012;153:4111–9.10.1210/en.2012-1435Search in Google Scholar PubMed PubMed Central
35. Adam CL, Findlay PA. Decreased blood-brain leptin transfer in an ovine model of obesity and weight loss: resolving the cause of leptin resistance. Int J Obes (Lond) 2010;34:980–8.10.1038/ijo.2010.28Search in Google Scholar PubMed
36. Zhang Y, Wang Y, Bao C, Xu Y, Shen H, et al. Metformin interacts with AMPK through binding to γ subunit. Mol Cell Biochem 2012;368:69–76.10.1007/s11010-012-1344-5Search in Google Scholar PubMed
37. Viollet B, Andreelli F. AMP-activated protein kinase and metabolic control. Handb Exp Pharmacol 2011;(203):303–30.10.1007/978-3-642-17214-4_13Search in Google Scholar PubMed PubMed Central
38. Lv WS, Wen JP, Li L, Sun RX, Wang J, et al. The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats. Brain Res 2012;1444:11–9.10.1016/j.brainres.2012.01.028Search in Google Scholar PubMed
39. Aubert G, Mansuy V, Voirol MJ, Pellerin L, Pralong FP. The anorexigenic effects of metformin involve increases in hypothalamic leptin receptor expression. Metabolism 2011;60:327–34.10.1016/j.metabol.2010.02.007Search in Google Scholar PubMed
40. Pimentel GD, Ropelle ER, Rocha GZ, Carvalheira JB. The role of neuronal AMPK as a mediator of nutritional regulation of food intake and energy homeostasis. Metabolism 2012;62:171–8.10.1016/j.metabol.2012.07.001Search in Google Scholar PubMed
41. Stark R, Ashley SE, Andrews ZB. AMPK and the neuroendocrine regulation of appetite and energy expenditure. Mol Cell Endocrinol 2013;366:215–23.10.1016/j.mce.2012.06.012Search in Google Scholar PubMed
42. Garfield AS, Patterson C, Skora S, Gribble FM, Reimann F, et al. Neurochemical characterization of body weight-regulating leptin receptor neurons in the nucleus of the solitary tract. Endocrinology 2012;153:4600–7.10.1210/en.2012-1282Search in Google Scholar PubMed PubMed Central
43. Haqq AM, Muehlbauer M, Svetkey LP, Newgard CB, Purnell JQ, et al. Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones. Clin Endocrinol (Oxf) 2007;67:944–51.10.1111/j.1365-2265.2007.02991.xSearch in Google Scholar PubMed PubMed Central
44. Haqq AM, Muehlbauer MJ, Newgard CB, Grambow S, Freemark M. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. J Clin Endocrinol Metab 2011;96:E225–32.10.1210/jc.2010-1733Search in Google Scholar PubMed PubMed Central
©2014 by Walter de Gruyter Berlin Boston
